Search
Showing results for "clinical trials"
Contact us If you'd like to get in touch, please contact us by phone or email. Phone: 0400 450 240 Email: vtg@thekids.org.au Pneumococcal disease is
This short report highlights the requirement for contemporary age-specific normative data from a larger number of biopsies, including typically developing children
Streptococcus A is a bacterium often found in the throat and on the skin.
Chronic obstructive pulmonary disease (COPD) is a complex disorder with a high degree of interindividual variability. Gastrointestinal dysfunction is common in patients with COPD and has been proposed to influence the clinical progression of the disease. Using the presence of bile acid(s) (BA) in bronchoalveolar lavage (BAL) fluid as a marker of gastric aspiration, we evaluated the relationships between BAs, clinical outcomes and bacterial lung colonisation.
With advances in perinatal care, we have achieved major reductions in mortality in premature and critically ill infants, but they still remain at increased risk of neurodevelopmental disability. In this context, recent advances in neuroimaging are perceived as an addition of significant value to current clinical developmental screening programs.
A clinical trial-based economic evaluation was performed in which the net costs and effectiveness of the two treatment modalities were calculated and...
Mirko is a medically trained research-focused academic with a background in developmental psychology, psychometrics, and big data science. His research takes a life-span perspective and is driven by the urgent need to improve outcomes for people on the autism spectrum and with other neurodevelopmental and neuropsy
This project aims to determine the prevalence of chronic wet cough, PBB and middle ear disease in Aboriginal children in Aboriginal communities in the Kimberley.
This review provides a structured approach to assist in formulating person-specific exercise management plans for young people with T1D
Routine MPS screening for Maturity-onset diabetes of the young in the pediatric population with diabetes could reduce health system costs and improve patient QoL